- Home
- MTNB vs RELI Comparison
MTNB vs RELI Comparison
Compare MTNB & RELI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MTNB | RELI |
|---|---|---|
| Founded | 2013 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Specialty Insurers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.1M | 4.7M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | MTNB | RELI |
|---|---|---|
| Price | $0.82 | $0.67 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 29.9K | ★ 2.1M |
| Earning Date | 11-10-2025 | 11-06-2025 |
| Dividend Yield | N/A | ★ 4.38% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $13,115,995.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.47 | $0.61 |
| 52 Week High | $3.09 | $5.11 |
Technical Indicators
Market Signals| Indicator | MTNB | RELI |
|---|---|---|
| Relative Strength Index (RSI) | 36.02 | 41.79 |
| Support Level | $0.76 | $0.68 |
| Resistance Level | $0.98 | $0.83 |
| Average True Range (ATR) | 0.12 | 0.06 |
| MACD | 0.03 | 0.01 |
| Stochastic Oscillator | 33.67 | 23.41 |
Price Performance
Historical ComparisonAbout MTNB Matinas Biopharma Holdings Inc.
Matinas BioPharma Holdings Inc is a clinical-stage biopharmaceutical company with a focus on identifying and developing novel pharmaceutical products. The firm's pipeline includes MAT2203, MAT2501, and others.
About RELI Reliance Global Group Inc.
Reliance Global Group Inc operates as a holding company with diversified interests in the insurance market, as well as other related sectors. The company focuses on growing by pursuing acquisition strategies, initially and focused on wholesale and retail insurance agencies. Its primary strategies is to identify specific risks to reward arbitrage opportunities and develop these on a national platform, thereby increasing revenues and returns, and then identify and acquire undervalued wholesale and retail insurance agencies with operations in growing or underserved segments, expand and optimize their operations, and achieve asset value appreciation while generating interim cash flows. The company generates revenue in the form of commissions.